New shot challenges pill in battle against high cholesterol
NCT ID NCT06431763
First seen Jan 06, 2026 · Last updated May 22, 2026 · Updated 20 times
Summary
This study tested two drugs—inclisiran (a shot) and bempedoic acid (a pill)—in 402 adults with heart disease and high LDL cholesterol despite taking statins. The goal was to see which drug lowers cholesterol more effectively. Participants were already on maximum statin therapy, and the results could help doctors choose the best add-on treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis Investigative Site
Mannheim, Baden-Wurttemberg, 68305, Germany
-
Novartis Investigative Site
Stuttgart, Baden-Wurttemberg, 70376, Germany
-
Novartis Investigative Site
Lichtenfels, Bavaria, 96215, Germany
-
Novartis Investigative Site
Muehldorf Am Inn, Bavaria, 84453, Germany
-
Novartis Investigative Site
Regensburg, Bavaria, 93053, Germany
-
Novartis Investigative Site
Sulzbach-Rosenberg, Bavaria, 92237, Germany
-
Novartis Investigative Site
Frankfurt am Main, Hesse, 60389, Germany
-
Novartis Investigative Site
Frankfurt am Main, Hesse, 60590, Germany
-
Novartis Investigative Site
Frankfurt am Main, Hesse, 60594, Germany
-
Novartis Investigative Site
Göttingen, Lower Saxony, 37075, Germany
-
Novartis Investigative Site
Essen, North Rhine-Westphalia, 45355, Germany
-
Novartis Investigative Site
Koeln Nippes, North Rhine-Westphalia, 50733, Germany
-
Novartis Investigative Site
Löhne, North Rhine-Westphalia, 32584, Germany
-
Novartis Investigative Site
Kaiserslautern, Rhineland-Palatinate, 67655, Germany
-
Novartis Investigative Site
Dresden, Saxony, 01099, Germany
-
Novartis Investigative Site
Dresden, Saxony, 01307, Germany
-
Novartis Investigative Site
Leipzig, Saxony, 04209, Germany
-
Novartis Investigative Site
Jena, Thuringia, 07740, Germany
-
Novartis Investigative Site
Aachen, 52074, Germany
-
Novartis Investigative Site
Bad Homburg, 61348, Germany
-
Novartis Investigative Site
Bad Krozingen, 79189, Germany
-
Novartis Investigative Site
Bad Oeynhausen, 32545, Germany
-
Novartis Investigative Site
Bamberg, 96049, Germany
-
Novartis Investigative Site
Berlin, 10367, Germany
-
Novartis Investigative Site
Berlin, 13347, Germany
-
Novartis Investigative Site
Berlin, 13353, Germany
-
Novartis Investigative Site
Bochum, 44789, Germany
-
Novartis Investigative Site
Bochum, 44791, Germany
-
Novartis Investigative Site
Bremen, 28277, Germany
-
Novartis Investigative Site
Dessau, 06846, Germany
-
Novartis Investigative Site
Dresden, 01307, Germany
-
Novartis Investigative Site
Erfurt, 99097, Germany
-
Novartis Investigative Site
Essen, 45147, Germany
-
Novartis Investigative Site
Essen, 45355, Germany
-
Novartis Investigative Site
Falkensee, 14612, Germany
-
Novartis Investigative Site
Gladbeck, 45968, Germany
-
Novartis Investigative Site
Hamburg, 21109, Germany
-
Novartis Investigative Site
Hamburg, 22041, Germany
-
Novartis Investigative Site
Hamburg, 22607, Germany
-
Novartis Investigative Site
Hoyerswerda, 02977, Germany
-
Novartis Investigative Site
Kassel, 34121, Germany
-
Novartis Investigative Site
Kiel, 24105, Germany
-
Novartis Investigative Site
Ludwigshafen, 67067, Germany
-
Novartis Investigative Site
Magdeburg, 39120, Germany
-
Novartis Investigative Site
Markkleeberg, 04416, Germany
-
Novartis Investigative Site
Meissen, 01662, Germany
-
Novartis Investigative Site
Münster, 48149, Germany
-
Novartis Investigative Site
Offenbach, 63065, Germany
-
Novartis Investigative Site
Papenburg, 26871, Germany
-
Novartis Investigative Site
Pirna, 01796, Germany
-
Novartis Investigative Site
Potsdam, 14471, Germany
-
Novartis Investigative Site
Rüdersdorf, 15562, Germany
-
Novartis Investigative Site
Saint Ingbert Oberw, 66386, Germany
-
Novartis Investigative Site
Ulm, 89077, Germany
-
Novartis Investigative Site
Völklingen, 66333, Germany
Conditions
Explore the condition pages connected to this study.